<VariationArchive RecordType="classified" VariationID="1339420" VariationName="NM_001723.7(DST):c.7429del (p.Leu2477fs)" VariationType="Deletion" Accession="VCV001339420" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2022-02-10" MostRecentSubmission="2022-02-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1330519" VariationID="1339420">
      <GeneList>
        <Gene Symbol="DST" FullName="dystonin" GeneID="667" HGNC_ID="HGNC:1090" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>6p12.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="56457996" stop="56954830" display_start="56457996" display_stop="56954830" Strand="-" />
          </Location>
          <OMIM>113810</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001723.7(DST):c.7429del (p.Leu2477fs)</Name>
      <CanonicalSPDI>NC_000006.12:56616037:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>6p12.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="6" Accession="NC_000006.12" start="56616038" stop="56616038" display_start="56616038" display_stop="56616038" variantLength="1" positionVCF="56616037" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="6" Accession="NC_000006.11" start="56480836" stop="56480836" display_start="56480836" display_stop="56480836" variantLength="1" positionVCF="56480835" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>L2477fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.11" sequenceAccession="NC_000006" sequenceVersion="11" change="g.56480838del" Assembly="GRCh37">
            <Expression>NC_000006.11:g.56480838del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000006.12" sequenceAccession="NC_000006" sequenceVersion="12" change="g.56616040del" Assembly="GRCh38">
            <Expression>NC_000006.12:g.56616040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029322.2" sequenceAccession="NG_029322" sequenceVersion="2" change="g.343591del">
            <Expression>NG_029322.2:g.343591del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001723.7" sequenceAccession="NM_001723" sequenceVersion="7" change="c.7429del" MANEPlusClinical="true">
            <Expression>NM_001723.7:c.7429del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001714.1" sequenceAccession="NP_001714" sequenceVersion="1" change="p.Leu2477fs">
            <Expression>NP_001714.1:p.Leu2477fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144769.5" sequenceAccession="NM_001144769" sequenceVersion="5" change="c.4831-1554del">
            <Expression>NM_001144769.5:c.4831-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374722.1" sequenceAccession="NM_001374722" sequenceVersion="1" change="c.4930-1554del">
            <Expression>NM_001374722.1:c.4930-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374736.1" sequenceAccession="NM_001374736" sequenceVersion="1" change="c.4930-1554del" MANESelect="true">
            <Expression>NM_001374736.1:c.4930-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374734.1" sequenceAccession="NM_001374734" sequenceVersion="1" change="c.4957-1554del">
            <Expression>NM_001374734.1:c.4957-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001144770.2" sequenceAccession="NM_001144770" sequenceVersion="2" change="c.4417-1554del">
            <Expression>NM_001144770.2:c.4417-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374730.1" sequenceAccession="NM_001374730" sequenceVersion="1" change="c.4297-1554del">
            <Expression>NM_001374730.1:c.4297-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001386100.1" sequenceAccession="NM_001386100" sequenceVersion="1" change="c.4297-1554del">
            <Expression>NM_001386100.1:c.4297-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_183380.4" sequenceAccession="NM_183380" sequenceVersion="4" change="c.4297-1554del">
            <Expression>NM_183380.4:c.4297-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374729.1" sequenceAccession="NM_001374729" sequenceVersion="1" change="c.4297-1554del">
            <Expression>NM_001374729.1:c.4297-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015548.5" sequenceAccession="NM_015548" sequenceVersion="5" change="c.3319-1554del">
            <Expression>NM_015548.5:c.3319-1554del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="113810.0007" DB="OMIM" />
        <XRef Type="rs" ID="2152728832" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001723.7(DST):c.7429del (p.Leu2477fs) AND Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency" Accession="RCV001824084" Version="1">
        <ClassifiedConditionList TraitSetID="11988">
          <ClassifiedCondition DB="MedGen" ID="C3809470">Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-02-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-02-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-02-10" MostRecentSubmission="2022-02-10">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">33471381</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="11988" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18300" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex, autosomal recessive 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency</ElementValue>
                <XRef ID="MONDO:0014180" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa simplex due to BP230 deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EBS3</ElementValue>
                <XRef Type="MIM" ID="615425" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17690" />
                <XRef ID="17690" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Epidermolysis bullosa simplex (EBS) is characterized by fragility of the skin (and mucosal epithelia in some instances) that results in non-scarring blisters and erosions caused by minor mechanical trauma. EBS is distinguished from other types of epidermolysis bullosa (EB) or non-EB skin fragility syndromes by the location of the blistering in relation to the dermal-epidermal junction. In EBS, blistering occurs within basal keratinocytes. The severity of blistering ranges from limited to hands and feet to widespread involvement. Additional features can include hyperkeratosis of the palms and soles (keratoderma), nail dystrophy, milia, and hyper- and/or hypopigmentation. Rare EBS subtypes have been associated with additional clinical features including pyloric atresia, muscular dystrophy, cardiomyopathy, and/or nephropathy.</Attribute>
                <XRef ID="NBK1369" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301543</ID>
                <ID Source="BookShelf">NBK1369</ID>
              </Citation>
              <XRef ID="412181" DB="Orphanet" />
              <XRef ID="C3809470" DB="MedGen" />
              <XRef ID="MONDO:0014180" DB="MONDO" />
              <XRef Type="MIM" ID="615425" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4064111" SubmissionDate="2022-02-03" DateLastUpdated="2022-02-10" DateCreated="2022-02-10">
        <ClinVarSubmissionID localKey="113810.0007_EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY" title="DST, 1-BP DEL, 7429C_EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY" />
        <ClinVarAccession Accession="SCV002073660" DateUpdated="2022-02-10" DateCreated="2022-02-10" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-03">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">For discussion of the 1-bp deletion (c.7429delC) in the DST gene, causing a frameshift predicted to result in a premature termination codon (Leu2477SerfsTer13), that was found in compound heterozygous state in an Israeli brother and sister of Indian origin (family B) with epidermolysis bullosa simplex (EBS3; 615425) by Ganani et al. (2021), see 113810.0006.</Attribute>
              <Citation>
                <ID Source="PubMed">33471381</ID>
              </Citation>
              <XRef DB="OMIM" ID="615425" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DST" />
          </GeneList>
          <Name>DST, 1-BP DEL, 7429C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 7429C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="113810.0007" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4064111" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA SIMPLEX 3, LOCALIZED OR GENERALIZED INTERMEDIATE, WITH BP230 DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C3809470" Name="Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

